Protagenic Therapeutics, Inc. (PTIX)
NASDAQ: PTIX · Real-Time Price · USD
2.880
-0.155 (-5.11%)
At close: Aug 6, 2025, 4:00 PM
2.900
+0.020 (0.69%)
After-hours: Aug 6, 2025, 6:37 PM EDT
Exscientia Employees
The last reported number of employees for Protagenic Therapeutics was 3.
Employees
3
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
17.76M
No historical employees data available.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PTIX News
- 2 months ago - Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity - Accesswire
- 2 months ago - Gold Gains Over 1%; Protagenic Therapeutics Shares Spike Higher - Benzinga
- 2 months ago - Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders - Accesswire
- 3 months ago - Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split - Accesswire
- 9 months ago - Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million - Accesswire
- 10 months ago - Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million - Accesswire
- 1 year ago - Protagenic Therapeutics Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial - Accesswire
- 1 year ago - Protagenic Therapeutics' Innovative Peptide PT00114 to be Highlighted at Boston Summit - Accesswire